ARCHIVES

FDA Approves Votrient For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

Other Institutes Fare Well With ’77 Appropriations

August 20, 1976

Reagan Signs Appropriations Bill, Vetoes Biomedical Research Authorization Measure; Capitol Hill Angry

November 16, 1984

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984